You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 299 No. 10, March 12, 2008 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Research Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (5)
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Similar articles in JAMA
 Topic Collections
 •Nutritional and Metabolic Disorders
 •Lipids and Lipid Disorders
 •Women's Health
 •Pregnancy and Breast Feeding
 •Prognosis/ Outcomes
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Plasma Anandamide Concentration and Pregnancy Outcome in Women With Threatened Miscarriage

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Approximately 40% to 50% of all human conceptions are lost before 20 weeks of gestation.1 Recent animal studies suggest that the endocannabinoid anandamide (N-arachidonoyl-ethanolamine) is critical for both the synchronous development of the blastocyst and the endometrium in preparation for implantation, with low anandamide levels essential for successful implantation.2 Plasma anandamide levels are regulated by fatty acid amide hydrolase (FAAH), the enzyme (up-regulated by progesterone) that metabolizes anandamide into arachidonic acid and ethanolamine.3 Increased FAAH expression and lower anandamide levels have been demonstrated at the implantation site and low FAAH expression and high anandamide levels at the interimplantation site prior to successful implantation.2 Levels of FAAH in peripheral blood mononuclear cells from uncomplicated early pregnancies were significantly lower in women who subsequently miscarried.4 In women undergoing in vitro fertilization and embryo transfer, high plasma anandamide level at 6 weeks after embryo transfer was associated with . . . [Full Text of this Article]

Methods

Osama M. H. Habayeb, MBBS; Anthony H. Taylor, PhD; Mark Finney, MBchB
Reproductive Sciences Section

Mark D. Evans, PhD
Radiation and Oxidative Stress Group

Justin C. Konje, MD
jck4@le.ac.uk
Endocannabinoid Research Group
Reproductive Sciences Section
Department of Cancer Studies and Molecular Medicine
University of Leicester
Leicester Royal Infirmary
Leicester, Leicestershire, United Kingdom



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTERS

Anandamide as a Marker of Human Disease
Mauro Maccarrone
JAMA. 2008;300(3):281-282.
EXTRACT | FULL TEXT  

Anandamide as a Marker of Human Disease—Reply
Osama M. H. Habayeb, Anthony H. Taylor, and Justin C. Konje
JAMA. 2008;300(3):282.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Characterization of Anandamide-Stimulated Cannabinoid Receptor Signaling in Human ULTR Myometrial Smooth Muscle Cells
Brighton et al.
Mol. Endocrinol. 2009;23:1415-1427.
ABSTRACT | FULL TEXT  

Fluctuation in anandamide levels from ovulation to early pregnancy in in-vitro fertilization-embryo transfer women, and its hormonal regulation
El-Talatini et al.
Hum Reprod 2009;24:1989-1998.
ABSTRACT | FULL TEXT  

Endocannabinoids and reproductive biology
Maccarrone
Hum Reprod 2009;24:1771-1771.
FULL TEXT  

Anandamide as a Marker of Human Disease
Maccarrone
JAMA 2008;300:281-282.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.